Adjunct Associate Professor
Epidemiology & Public Health
President, LaKind Associates, LLC; Fellow by Courtesy, Department of Applied Mathematics and Statistics, Johns Hopkins University
106 Oakdale Avenue Catonsville, MD 21228
Education and Training
PhD - The Johns Hopkins University; Geography and Environmental Engineering; 1988
MS - The University of Wisconsin, Madison; Geology; 1984
BA - The Johns Hopkins University; Earth and Planetary Sciences; 1982
Judy LaKind, Ph.D., President of LaKind Associates, LLC, and Adjunct Associate Professor, Department of Epidemiology and Public Health, University of Maryland School of Medicine is a health and environmental scientist with expertise in exposure science, assessment of human health risks, biomonitoring, scientific and technical analysis for regulatory support, and systematic reviews. Dr. LaKind is also the past President of the International Society of Exposure Science.
Dr. LaKind has spoken and published extensively on exposure- and risk-related issues, including children’s exposures to environmental chemicals, the implications of uncertainty in the risk assessment process, weighing potential risks and benefits related to chemical use, the presence of environmental chemicals in human milk, and time-dependence and distributional analysis of exposure.
She serves on the editorial boards of the Journal of Toxicology and Environmental Health and Environment International and is past Associate Editor for the Journal of Exposure Science and Environmental Epidemiology.
exposure science, biomonitoring, systematic review, risk assessment
LaKind JS, Burns CJ, Pottenger LH, Naiman DQ, Goodman JE, Marchitti SA. 2021. Does ozone inhalation cause adverse metabolic effects in humans? A systematic review. Critical Reviews in Toxicology In press.
Verner M-A, Salame H, Housand C, Birnbaum LS, Bouchard M, Chevrier J, Aylward L, Naiman DQ, LaKind JS. 2020. How many urine samples are needed to accurately assess exposure to nonpersistent chemicals? The Biomarker Reliability Assessment Tool (BRAT) for scientists, research sponsors and risk managers. International Journal of Environmental Research and Public Health 17, 9102; doi:10.3390/ijerph17239102.
Brozek J, Canelo C, Akl E, Bowen J, Bucher J, Chiu W, Cronin M, Djulbegovic B, Falavigna M, Guyatt G, Gordon A, Hilton Boon M, Hutubessy R, Joore M, Katikireddi S, LaKind J, Langendam M, Manja V, Magnuson K, Mathioudakis A, Meerpohl J, Mertz D, Mezencev R, Morgan R, Morgano GP, Mustafa R, Naidoo B, O'Flaherty M, Patlewicz G, Riva J, Posso M, Ringborg A, Rooney A, Schlosser P, Schwartz L, Shemilt I, Tarride J-E, Thayer K, Tsaioun K, Vale L, Wambaugh J, Wignall JA, Williams AR, Xie F, Zhang Y, Schünemann H. 2020. GRADE Guidelines 30: The GRADE Approach to Assessing the Certainty of Evidence from Models – an Overview in the Context of Health Decision-making. Journal of Clinical Epidemiology S0895- 4356(20)31103-3.
Goodman M, Li J, Flanders WD, Mahood D, Anthony LG, Zhang Q, LaKind JS. 2020. Epidemiology of PCBs and neurodevelopment: Systematic assessment of multiplicity and completeness of reporting. Global Epidemiology 2:100040.
LaKind JS, Naiman J, Burns CJ. Translation of exposure and epidemiology for risk assessment: A shifting paradigm. 2020. International Journal of Environmental Research and Public Health 17(12):4220; https://doi.org/10.3390/ijerph17124220.
LaKind JS, Burns CJ, Erickson H, Graham SE, Jenkins S, Johnson GT. 2020. Bridging the epidemiology risk assessment gap: An NO2 case study of the Matrix. Global Epidemiology 2:100017.
LaKind JS, Goodman M. 2019. Methodological evaluation of human research on asthmagenicity and occupational cleaning: A case study of quaternary ammonium compounds (“quats”). Allergy, Asthma & Clinical Immunology 15:69.
Burns CJ, LaKind JS, Mattison DR, Alcala CS, Branch F, Castillo J, Clark A, Clougherty JE, Darney SP, Erickson H, Goodman M, Greiner M, Jurek AM, Miller A, Rooney AA, Zidek A. 2019. A Matrix for bridging the epidemiology and risk assessment gap. Global Epidemiology 1: 100005.
LaKind JS, Idri F, Naiman DQ, Verner M-A. 2019. Biomonitoring and nonpersistent chemicals – understanding and addressing variability and exposure misclassification. Current Environmental Health Reports 6(1):16-21.
LaKind JS, Davis M, Lehmann GM, Hines E, Marchitti SA, Alcala C, Lorber M. 2019. Infant dietary exposures to environmental chemicals and infant/child health: A critical assessment of the literature. Environmental Health Perspectives 126(9):96002. Highlighted in: Arnold C. 2019. Baby steps forward: Recommendations for better understanding environmental chemicals in breast milk and infant formula. Environmental Health Perspectives https://doi.org/10.1289/EHP4804
Lehmann GM, LaKind JS, Davis M, Hines E, Marchitti SA, Alcala C, Lorber M. 2019. Environmental chemicals in breast milk and formula: Exposure and risk assessment implications. Environmental Health Perspectives 126(9):96001.
American Chemical Society, Environmental Division
International Society of Exposure Science (ISES), former President
Society for Risk Analysis
Society of Toxicology
SOT Exposure Specialty Section, founding member
Online Continuing Education Module: Chemical Exposures and Health Effects